Cited by 188Fibroblast Growth Factor ResearchMetabolism, Diabetes, and CancerLiver physiology and pathology

Glucose induces FGF21 mRNA expression through ChREBP activation in rat hepatocytes

Open access
Iizuka, Katsumi, Takeda, Jun, Horikawa, Yukio·2009·FEBS Letters

Abstract

Fibroblast growth factor 21 (FGF21) has beneficial effects of improving the plasma glucose and lipid profiles in diabetic rodents. Here, we investigated carbohydrate response element binding protein (ChREBP) involvement in the regulation of FGF21 mRNA expression in liver. Glucose stimulation and adenoviral overexpression of dominant active ChREBP increased FGF21 mRNA. Consistently, adenoviral expression of dominant negative Mlx inhibited glucose induction of FGF21 mRNA. Furthermore, deletion studies of mouse FGF21 gene promoter (−2000 to +65 bp) revealed a glucose responsive region between −74 and −52 bp. These findings suggest that FGF21 expression is regulated by ChREBP.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.febslet.2009.07.053

Cites

25 of 25 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Hepatic mRNA and plasma protein levels of FGF21 are induced by high sugar intake through a ChREBP-dependent mechanism.

    “Hepatic mRNA and plasma protein levels of FGF21 are induced by high sugar intake through a mechanism dependent on the transcription factor ChREBP22–25”

    From Metabolic messengers: FGF21 (2021) · cites this paper as [23]

  • Xylulose-5-phosphate activates ChREBP and promotes its binding to carbohydrate response element sites in promoters of target genes, including FGF21.

    “An intermediate in this pathway, xylulose-5-phosphate, activates ChREBP (1) and promotes its binding to the carbohydrate response element sites in the promoters of target genes, including FGF21 (53, 130).”
  • Stimulation of FGF21 production by carbohydrates is mediated by the transcription factor ChREBP.

    “The stimulation of FGF21 production by carbohydrates is mediated by the transcription factor carbohydrate-response element-binding protein (ChREBP).”
  • Circulating FGF21 levels are robustly increased by diets that are high in carbohydrate but low in protein.

    “Circulating FGF21 levels are robustly increased by diets that are high in carbohydrate but low in protein”
  • Liver FGF21 production is robustly stimulated by an imbalance in macronutrients, particularly settings of high-carbohydrate but low-protein intake.

    “liver FGF21 production seems to be robustly stimulated by an imbalance in macronutrients, particularly settings of high-carbohydrate but low-protein intake”

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Iizuka, K., Takeda, J., & Horikawa, Y.
Affiliations
  • Gunma University (JP)
  • Gifu University (JP)
Corresponding author
Horikawa, Yukio
Venue
FEBS Letters
Publisher
Wiley
Published
2009-08-04
Volume
583
Issue
17
Pages
2882-2886
ISSN
  • 0014-5793 (ISSN-L)
  • 1873-3468
OpenAlex
W2075349430
Cited by
187
References
25
Citations by year
2026: 5 · 2025: 12 · 2024: 6 · 2023: 9 · 2022: 15 · 2021: 22 · 2020: 8 · 2019: 16 · 2018: 12 · 2017: 18 · 2016: 20 · 2015: 13 · 2014: 7 · 2013: 6 · 2012: 10
FWCI
2.55
Type
journal article
Language
en
Open access
Locations
  • FEBS Letters (publishedVersion)
  • PubMed (publishedVersion)
Funders
  • Japan Society for the Promotion of Science
  • New Energy and Industrial Technology Development Organization
  • Health and Labor Science Research Grant for Research on Human Genome
  • Japanese Ministry of Health, Labor and Welfare
  • ONO Medical Research Foundation
  • Kao Research Council for the Study of Healthcare Science
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Fibroblast Growth Factor Research
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Metabolism, Diabetes, and Cancer
  • Health Sciences › Medicine › Hepatology › Liver physiology and pathology
Keywords
FGF21, ChREBP, glucose, hepatocytes, MLX, transcriptional regulation
MeSH terms
Animals, Cells, Cultured, Fibroblast Growth Factors, Glucose, Promoter Regions, Genetic, RNA, Messenger, Transcriptional Activation, Trans-Activators, Hepatocytes, Mice, Rats, Basic Helix-Loop-Helix Leucine Zipper Transcription Factors

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review